Psy97 - Cost-Effectiveness Analysis of Enzyme Replacement Therapy for Type 1 Gaucher Disease

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2672
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Cost-Effectiveness of Enzyme Replacement Therapy for Type 1 Gaucher Disease

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2014English

The Clinical Effectiveness and Cost-Effectiveness of Enzyme Replacement Therapy for Gaucher’s Disease: A Systematic Review

Clinical Governance: An International Journal
2007English

Russian Pediatric Experience on Assessing the Effectiveness of Imiglucerase for Long-Term Enzyme Replacement Therapy of Gaucher Disease Type 1 in Children

Vestnik Rossiiskoi Akademii Meditsinskikh Nauk
Medicine
2017English

Response to Enzyme Replacement Therapy in Patients With Gaucher Disease Type I

2019English

PP044 Adherence to Enzyme Replacement Therapy in Gaucher Disease

International Journal of Technology Assessment in Health Care
Health Policy
2017English

Enzyme Replacement in Gaucher Disease

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2004English

Psy51 - Clinical and Economic Aspects of Enzyme Replacement Therapy in Russian Patients With Gaucher Disease Type 1

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Cost-Effectiveness of Enzyme Replacement Therapy With Alglucosidase Alfa in Adult Patients With Pompe Disease

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2017English

Limited Data to Evaluate Real‐World Effectiveness of Enzyme Replacement Therapy for Mucopolysaccharidosis Type I

Journal of Inherited Metabolic Disease
Genetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy